ARCHIVES

In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER

This article is from The Cancer Letter archive.

Vol. 18 No. 12 | March 20, 1992

Download PDF Visit The Full Archive

Related Articles

Brachytherapy Prevents Endometrial Cancer Return

June 27, 2008

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993

In Congress: Conferees Approve 42 billion Increase For NIH Appropriations

October 29, 1999

Clinical Trials Approved By NCI Listed For September

September 24, 2004

In Brief: NCI Awards 4 Contracts For Enrichment Program; Dana-Farber Names Breast Center Leadership

July 10, 1992

Harkin, Hatfield Propose Cigarette Tax To Fund NIH Research

September 22, 1995